Literature DB >> 2581123

Conformational features of calcium channel agonist and antagonist analogs of nifedipine.

D A Langs, D J Triggle.   

Abstract

The crystal and molecular structures of methyl 2,6-dimethyl-5-nitro-4-(2-trifluoromethylphenyl)-1,4- dihydropyridine-3-carboxylate and ethyl 4-(2-difluoromethoxyphenyl)-1,4,5,7,-tetrahydro-2-methyl-5-oxof uro[3,4-b]pyridine-3-carboxylate, which are analogs of the calcium channel antagonist nifedipine reported to have agonist activity, have been determined. The conformations of these two agonists are compared with the conformational features shown by nifedipine and related 1,4-dihydropyridine calcium channel antagonists. Common conformational features shown by these agonists and antagonists allow both to bind to the same plasma membrane receptor while subtle differences in hydrogen-bonding activity of the amine group, and ester group orientation and hydrophobic fit, may control the availability of channel open and closed states.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581123

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  RS 30026: a potent and effective calcium channel agonist.

Authors:  L Patmore; G P Duncan; B Clarke; A J Anderson; R Greenhouse; J R Pfister
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

2.  Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.

Authors:  D A Langs; Y W Kwon; P D Strong; D J Triggle
Journal:  J Comput Aided Mol Des       Date:  1991-04       Impact factor: 3.686

3.  Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers.

Authors:  D W Chester; L G Herbette; R P Mason; A F Joslyn; D J Triggle; D E Koppel
Journal:  Biophys J       Date:  1987-12       Impact factor: 4.033

4.  Novel halogenated dihydropyridine derivatives with high vascular selectivity.

Authors:  U Fricke; W Klaus; B Stein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

5.  1,1'-[4-(2,4-Dichloro-phen-yl)-2,6-di-methyl-1,4-di-hydro-pyridine-3,5-di-yl]diethanone.

Authors:  J Kalyana Sundar; B Palakshi Reddy; V Vijayakumar; S Natarajan; J Suresh; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.